This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Shandong Xinchuang Biological Technology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Xiaotian Chang - Innovator in Tumor Marker Research
Introduction: Xiaotian Chang is an inventor based in Jinan, China. He is associated with Shandong Xinchuang Biological Technology Co., Ltd. Despite having no granted patents to his name, he is actively involved in innovative research related to tumor markers.
Latest Patent Applications: Xiaotian Chang's notable patent application is titled "Antigen and Antibodies Prepared Based on PADI4 Serving as Tumor Marker, and Application Thereof." This application discloses an antigen and antibodies prepared based on peptidylarginine deiminase (PADI4) serving as a tumor marker. The antigen has an amino acid sequence shown as SEQ ID NO. 1. Specific antibodies prepared using the antigen are also disclosed. The protein PADI4 monoclonal antibodies include a protein PADI4 monoclonal antibody coated onto an ELISA plate and a biotin-labeled protein PADI4 monoclonal antibody. A kit prepared using the antibodies can effectively and stably determine a protein PADI4 level in human serum, demonstrating broad spectrum, detectability, and high test repeatability.
Conclusion: Xiaotian Chang is making significant contributions to the field of tumor marker research through his innovative applications. His work has the potential to advance diagnostic methods in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile